$CHTH
CNL Healthcare Properties, Inc.

2022 Q2 Form 10-Q Financial Statement

#000095017022009689 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q1
Revenue $81.04M $78.60M $72.08M
YoY Change 10.51% 9.04% -11.82%
Cost Of Revenue $60.35M $58.85M $50.93M
YoY Change 19.59% 15.56% -1.64%
Gross Profit $20.69M $19.75M $21.16M
YoY Change -9.5% -6.67% -29.4%
Gross Profit Margin 25.54% 25.12% 29.35%
Selling, General & Admin $5.964M $6.210M $6.717M
YoY Change -6.59% -7.55% -0.03%
% of Gross Profit 28.82% 31.45% 31.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.00M $12.80M $12.40M
YoY Change 6.56% 3.23% 0.0%
% of Gross Profit 62.82% 64.82% 58.61%
Operating Expenses $748.0K $807.0K $753.0K
YoY Change 3.89% 7.17% 12.72%
Operating Profit $839.0K -$105.0K $1.804M
YoY Change -79.9% -105.82% -84.69%
Interest Expense -$750.0K -$3.858M -$5.302M
YoY Change -83.74% -27.24% -22.47%
% of Operating Profit -89.39% -293.9%
Other Income/Expense, Net -$750.0K $4.518M $5.302M
YoY Change -83.74% -14.79% -177.53%
Pretax Income $89.00K $4.413M -$3.498M
YoY Change -120.37% -226.16% -170.78%
Income Tax $65.00K $85.00K -$1.300M
% Of Pretax Income 73.03% 1.93%
Net Earnings $1.000K $4.303M -$2.147M
YoY Change -99.83% -300.42% -145.28%
Net Earnings / Revenue 0.0% 5.47% -2.98%
Basic Earnings Per Share $0.00 $0.02
Diluted Earnings Per Share $5.75 $24.74K -$12.34K
COMMON SHARES
Basic Shares Outstanding 174.0M 174.0M
Diluted Shares Outstanding 174.0M shares 174.0M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.83M $51.48M $68.36M
YoY Change 1.02% -24.69%
Cash & Equivalents $65.83M $51.48M $72.30M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $65.83M $51.48M $68.36M
YoY Change 1.02% -24.69%
LONG-TERM ASSETS
Property, Plant & Equipment $1.351B $1.359B $1.382B
YoY Change -1.55% -1.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.59M $29.18M $17.77M
YoY Change 11.59% 64.24%
Total Long-Term Assets $1.386B $1.403B $1.424B
YoY Change -1.99% -1.43%
TOTAL ASSETS
Total Short-Term Assets $65.83M $51.48M $68.36M
Total Long-Term Assets $1.386B $1.403B $1.424B
Total Assets $1.451B $1.455B $1.492B
YoY Change -1.86% -2.5% -5.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.90M $26.97M $26.00M
YoY Change 3.62% 3.73%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.32M $28.49M $27.83M
YoY Change 3.52% 2.38%
LONG-TERM LIABILITIES
Long-Term Debt $607.8M $607.4M $597.6M
YoY Change 2.15% 1.64%
Other Long-Term Liabilities $7.235M $7.369M $8.398M
YoY Change 8.16% -12.25%
Total Long-Term Liabilities $615.0M $614.7M $606.0M
YoY Change 2.22% 1.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.32M $28.49M $27.83M
Total Long-Term Liabilities $615.0M $614.7M $606.0M
Total Liabilities $643.3M $643.2M $633.8M
YoY Change 2.28% 1.49% -8.15%
SHAREHOLDERS EQUITY
Retained Earnings $106.2M $106.2M $122.6M
YoY Change -13.82% -13.4%
Common Stock $1.519B $1.519B $1.519B
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $806.3M $809.8M $856.5M
YoY Change
Total Liabilities & Shareholders Equity $1.451B $1.455B $1.492B
YoY Change -1.86% -2.5%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $1.000K $4.303M -$2.147M
YoY Change -99.83% -300.42% -145.28%
Depreciation, Depletion And Amortization $13.00M $12.80M $12.40M
YoY Change 6.56% 3.23% 0.0%
Cash From Operating Activities $15.84M $8.236M $12.63M
YoY Change 37.02% -34.81% -29.27%
INVESTING ACTIVITIES
Capital Expenditures -$4.640M -$3.579M -$1.975M
YoY Change 135.17% 81.22% -20.97%
Acquisitions
YoY Change
Other Investing Activities $8.205M $0.00 -$35.00K
YoY Change -100.0% -100.04%
Cash From Investing Activities $3.565M -$4.713M $5.462M
YoY Change -280.69% -186.29% -93.14%
FINANCING ACTIVITIES
Cash Dividend Paid $4.453M $8.907M
YoY Change -50.01% 0.01%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.466M -5.090M -11.81M
YoY Change -61.97% -56.9% -63.45%
NET CHANGE
Cash From Operating Activities 15.84M 8.236M 12.63M
Cash From Investing Activities 3.565M -4.713M 5.462M
Cash From Financing Activities -4.466M -5.090M -11.81M
Net Change In Cash 14.94M -1.567M 6.285M
YoY Change -793.23% -124.93% -90.35%
FREE CASH FLOW
Cash From Operating Activities $15.84M $8.236M $12.63M
Capital Expenditures -$4.640M -$3.579M -$1.975M
Free Cash Flow $20.48M $11.82M $14.61M
YoY Change 51.33% -19.12% -28.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMember
CY2021Q4 us-gaap Assets
Assets
1436580000
CY2022Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMember
CY2021Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMember
CY2022Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMember
CY2022Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-02-29
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001496454
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
000-54685
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
CNL Healthcare Properties, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2876363
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
CNL Center at City Commons
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
450 South Orange Avenue
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
CY2022Q1 dei City Area Code
CityAreaCode
407
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
650-1000
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
173960540
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1359127000
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1338856000
CY2022Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
8312000
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
8373000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51483000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53161000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4631000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4520000
CY2022Q1 us-gaap Other Assets
OtherAssets
14943000
CY2021Q4 us-gaap Other Assets
OtherAssets
18700000
CY2022Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
16234000
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
12970000
CY2022Q1 us-gaap Assets
Assets
1454730000
CY2022Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
107285000
CY2021Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
89400000
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
500075000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
499728000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26967000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
29170000
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
7369000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
6115000
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1522000
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1406000
CY2022Q1 us-gaap Liabilities
Liabilities
643218000
CY2021Q4 us-gaap Liabilities
Liabilities
625819000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
537000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
520000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2021Q4 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2021Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2021Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2022Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1740000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1740000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
106164000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
101861000
CY2022Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
815946000
CY2021Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
811493000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
809044000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1436580000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
886000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
809770000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
1205000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1197000
CY2022Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
811512000
CY2021Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
810761000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1454730000
CY2022Q1 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
6865000
CY2021Q1 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
7274000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71732000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64809000
CY2022Q1 us-gaap Revenues
Revenues
78597000
CY2021Q1 us-gaap Revenues
Revenues
72083000
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
55333000
CY2021Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
47855000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2631000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2248000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13642000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12637000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
78702000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
70279000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-105000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1804000
CY2022Q1 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
5000
CY2021Q1 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
-2000
CY2022Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
3863000
CY2021Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
5281000
CY2022Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
8376000
CY2021Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-19000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4518000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5302000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4413000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3498000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1336000
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4328000
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2162000
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-10000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4328000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2172000
CY2022Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
25000
CY2021Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-25000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4303000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2147000
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.02
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.01
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.00
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4328000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2172000
CY2022Q1 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
876000
CY2021Q1 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
1000
CY2022Q1 chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
0
CY2021Q1 chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
2000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
876000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5204000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2169000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
25000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-25000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5179000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2144000
CY2021Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
810761000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4328000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
876000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0256
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4453000
CY2022Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
811512000
CY2020Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
869369000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2172000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
109000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0512
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8907000
CY2021Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
858184000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
8236000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
12640000
CY2022Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0
CY2021Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-7000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8236000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12633000
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1134000
CY2021Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2022Q1 chth Payment To Acquire Capital Expenditures Investing Activities
PaymentToAcquireCapitalExpendituresInvestingActivities
3579000
CY2021Q1 chth Payment To Acquire Capital Expenditures Investing Activities
PaymentToAcquireCapitalExpendituresInvestingActivities
1975000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-35000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4713000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1940000
CY2022Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0
CY2021Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
7402000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4713000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5462000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
4453000
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
8907000
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
642000
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2794000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
5000
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-109000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5090000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11810000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1567000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6285000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57681000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66011000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56114000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
72296000
CY2022Q1 us-gaap Contribution Of Property
ContributionOfProperty
29384000
CY2021Q1 us-gaap Contribution Of Property
ContributionOfProperty
0
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
4281000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0
CY2022Q1 us-gaap Transfer Mortgage Payable
TransferMortgagePayable
18468000
CY2021Q1 us-gaap Transfer Mortgage Payable
TransferMortgagePayable
0
CY2022Q1 chth Net Assets Recognized Upon The Change In Control Of Joint Venture
NetAssetsRecognizedUponTheChangeInControlOfJointVenture
15197000
CY2021Q1 chth Net Assets Recognized Upon The Change In Control Of Joint Venture
NetAssetsRecognizedUponTheChangeInControlOfJointVenture
0
CY2021 chth Number Of Properties Sold
NumberOfPropertiesSold
69
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xbrl_ts_699aa1c389e94ae99ac3ba1db7db33aa" style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> —</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor. Accordingly, actual results could differ from those estimates.</span></p>
CY2022Q1 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6311
CY2021Q1 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6107
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71700000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64800000
CY2022Q1 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2021Q1 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2022Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
138022000
CY2021Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
131257000
CY2022Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1511715000
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1500208000
CY2022Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
102178000
CY2021Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
101180000
CY2022Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
392788000
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
393789000
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1359127000
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1338856000
CY2022Q1 us-gaap Depreciation
Depreciation
12800000
CY2021Q1 us-gaap Depreciation
Depreciation
12400000
CY2022Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
8312000
CY2021Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
8373000
CY2022Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
8312000
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
8373000
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
10000
CY2022Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
13300000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
49000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
59000
CY2022Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
107285000
CY2021Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
89400000
CY2022Q1 chth Total Credit Facilities Net
TotalCreditFacilitiesNet
500075000
CY2021Q4 chth Total Credit Facilities Net
TotalCreditFacilitiesNet
499728000
CY2022Q1 chth Notes And Loans Payable Net
NotesAndLoansPayableNet
607360000
CY2021Q4 chth Notes And Loans Payable Net
NotesAndLoansPayableNet
589128000
CY2022Q1 us-gaap Minority Interest Ownership Percentage By Noncontrolling Owners
MinorityInterestOwnershipPercentageByNoncontrollingOwners
0.25
CY2022Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0250
CY2022Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
355000000.0
CY2021Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
355000000.0
CY2022Q1 chth Liquidity
Liquidity
83500000
CY2022Q1 chth Scheduled Payments In Future Period
ScheduledPaymentsInFuturePeriod
45700000
CY2022Q1 chth Material Maturity Amount
MaterialMaturityAmount
44700000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
45652000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
112054000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
452887000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
610593000
CY2022Q1 us-gaap Debt Instrument Restrictive Covenants
DebtInstrumentRestrictiveCovenants
The credit facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio, and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the credit facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the credit facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of March 31, 2022, the Company was in compliance with all financial covenants related to its Credit Facilities.
CY2022Q1 chth Financial Covenant Limitations Maximum Allowable Distributions As Percentage Of Adjusted Funds From Operations
FinancialCovenantLimitationsMaximumAllowableDistributionsAsPercentageOfAdjustedFundsFromOperations
0.95
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
807000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
753000
CY2022Q1 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
328000
CY2021Q4 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
214000
CY2022Q1 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
807000
CY2021Q1 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
753000
CY2022Q1 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
328000
CY2021Q4 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
214000
CY2022Q1 chth Relatedpartytransactioninvestmentservicescosts
Relatedpartytransactioninvestmentservicescosts
60000
CY2021Q1 chth Relatedpartytransactioninvestmentservicescosts
Relatedpartytransactioninvestmentservicescosts
0
CY2022Q1 chth Duetorelatedpartyinvestmentservicesfees
Duetorelatedpartyinvestmentservicesfees
0
CY2021Q4 chth Duetorelatedpartyinvestmentservicesfees
Duetorelatedpartyinvestmentservicesfees
0
CY2022Q1 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
3579000
CY2021Q1 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
4476000
CY2022Q1 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1194000
CY2021Q4 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1192000
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
4446000
CY2021Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5229000
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1522000
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1406000
CY2022Q1 chth Investment Services Fees
InvestmentServicesFees
100000
CY2022Q1 chth Capitalizedamountofinvestmentservicesfees
Capitalizedamountofinvestmentservicesfees
100000
CY2022Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.0256
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-100000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1300000
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000
CY2021Q1 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1400
CY2022Q1 chth Number Of Promoted Interest Agreements
NumberOfPromotedInterestAgreements
2
CY2022Q1 chth Number Of Promoted Interest Agreements Met Established Performance Metrics
NumberOfPromotedInterestAgreementsMetEstablishedPerformanceMetrics
0

Files In Submission

Name View Source Status
0000950170-22-009689-index-headers.html Edgar Link pending
0000950170-22-009689-index.html Edgar Link pending
0000950170-22-009689.txt Edgar Link pending
0000950170-22-009689-xbrl.zip Edgar Link pending
chth-20220331.htm Edgar Link pending
chth-20220331.xsd Edgar Link pending
chth-20220331_cal.xml Edgar Link unprocessable
chth-20220331_def.xml Edgar Link unprocessable
chth-20220331_htm.xml Edgar Link completed
chth-20220331_lab.xml Edgar Link unprocessable
chth-20220331_pre.xml Edgar Link unprocessable
chth-ex31_1.htm Edgar Link pending
chth-ex31_2.htm Edgar Link pending
chth-ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img262440787_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending